Felix Ampomah; Analyst; Stephens, Inc. Good morning ladies and gentlemen, and welcome to Fennec Pharmaceuticals fourth quarter and full year 2024 earnings and corporate update conference call.

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year. Revenue declined to $7.93 ...

FENNEC PHARMACEUTICALS ($FENC) posted quarterly earnings results on Monday, March 10th. The company reported earnings of -$0.06 per share, missing estimates of $0.17 ...

Early Repayment of $13 Million of the Company’s Approximately $32 Million Outstanding Convertible Debt Facility: In December 2024, Fennec announced the early partial repayment of a significant ...

(RTTNews) - Fennec Pharmaceuticals Inc (FENC) released Loss for fourth quarter that decreased from last year and beat the Street estimates. The company's earnings totaled -$1.62 million ...

Weighing in at around 1kg, the fennec fox is the smallest of all the foxes. As a resident across the Sahara desert and other parts of North Africa the fennec’s long hairs may seem a bit out of ...